Exane Derivatives’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.21K | Sell |
39
-1,206
| -97% | -$37.4K | ﹤0.01% | 488 |
|
|
2022
Q1 | $51.1K | Sell |
1,245
-425
| -25% | -$17.5K | 0.01% | 566 |
|
|
2021
Q4 | $72.6K | Sell |
1,670
-354
| -17% | -$15.4K | 0.02% | 462 |
|
|
2021
Q3 | $101K | Sell |
2,024
-333
| -14% | -$16.7K | 0.02% | 511 |
|
|
2021
Q2 | $137K | Sell |
2,357
-769
| -25% | -$44.5K | 0.03% | 493 |
|
|
2021
Q1 | $290K | Sell |
3,126
-1,273
| -29% | -$118K | 0.08% | 218 |
|
|
2020
Q4 | $394K | Buy |
+4,399
| New | +$394K | 0.12% | 201 |
|